Spotlight: June-August 2022

Updated: Sep 14

Words by Jade Williams

GOLD looks back at some of the top news stories from the pharmaceutical industry over the last few months, covering recent collaborations, drug approvals and much more


08 June

Gilead Sciences and Westminster Drug Project repartner to eliminate hepatitis C in drug and alcohol services by end of 2023


14 June

Merck and the Mulliken Centre enter three-year collaboration for machine learning project


20 June

University of Manchester researchers discover blood vessel link to halt Alzheimer’s progression


23 June

Novartis renews Kigali Declaration commitment, investing $250m over five years for neglected tropical diseases


30 June

Pfizer announces commitment to reach Net-Zero Standard ahead of schedule by 2040


05 July

Juvisé Pharmaceuticals completes €400m refinancing after acquiring rights to antimicrobial Pylera


12 July

ABPI sets new NHS data usage regulations for pharma companies


18 July

Long-awaited Haleon demerger completed by GSK


25 July

EC extends Bavarian Nordic’s Imvanex smallpox vaccine license to tackle monkeypox


28 July

GSK signs agreement to supply pandemic influenza vaccine Adjupanrix to 12 European countries


02 Aug

CSL Limited receives regulatory clearances to acquire Vifor Pharma, with Hervé Gisserot appointed as General Manager


04 Aug

Sanofi and Innovent Biologics collaborate to accelerate development of oncology medicines and expand presence in China


This article features in GOLD 23 – read the full issue here.